@MYTH©bubu et les 4 doses !

MYTH©bubu :  sans bras placebo 

Jan. 02, 2021  Pfizer/BioNTech to speed up vaccination of placebo arm in COVID-19 trial

The Vaccine Transition Option offers all participants 12 years and older the choice to learn whether they received the study vaccine or placebo, and for those who received the placebo, to have the option to receive the study vaccine while staying in the study.

According to Pfizer-BioNTech and Moderna, interim analyses after approximately 2 months of follow-up suggest their vaccines are 90% to 95% effective at preventing SARS-CoV-2 infection, although no peer review of the data has been conducted to date. Both companies now claim they have an “ethical obligation” to offer vaccine as soon as possible to all participants who received placebo, considering the strong results and participants’ contribution to the research

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials

Published Online : December 14, 2020

 « On est en phase de pharmacovigilance et ce n’est pas un essai clinique. La sécurité et l’efficacité sont clairement démontrés. »

Auteur anonyme, le 26 avril 2021

Heil Μπουρλά !